Rise In Demand For Personalized Medicines Driving The Growth Of The Market Due To Targeted And Patient-Specific Drug Delivery Is Supporting Development Across The Nanocarriers Market

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

How Does The Forecasted Market Size Of The Nanocarriers Market Compare Between 2026 And 2030?

The nanocarriers market has witnessed substantial expansion in recent years. Its size is projected to increase from $11.61 billion in 2025 to $13.74 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 18.4%. The historical development of this market can be attributed to various factors, including advancements in nanotechnology research, increasing investments in pharmaceutical research and development, a growing requirement for enhanced drug bioavailability, the early adoption of nanoparticle-based therapeutics, and the expansion of academic and clinical research.

The nanocarriers market is anticipated to experience significant expansion over the coming years. This market is projected to reach $26.74 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 18.1%. This expansion during the projection period stems from factors such as the increasing need for individualized treatments, greater capital allocation towards sophisticated drug delivery mechanisms, the broader application of nanocarriers in cancer treatment and gene therapy, an intensifying emphasis on minimizing drug adverse effects, and ongoing breakthroughs in nanoscale engineering. Key trends anticipated during the forecast period involve the increased creation of targeted drug delivery platforms, wider acceptance of lipid and polymeric nanocarriers, a stronger emphasis on controlled and prolonged release systems, the extended use of nanocarriers in delivering genes and vaccines, and improved incorporation into precision medicine strategies.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28275&type=smp

Which Growth Drivers Are Expected To Support The Nanocarriers Market Forward?

The escalating demand for personalized medicines is set to propel the expansion of the nanocarriers market. Personalized medicine involves customizing medical treatment for individual patients, leveraging their unique genetic, biomarker, and molecular information. This emphasis is growing because it empowers doctors to tailor cancer treatments to a patient’s genetic profile, thereby improving effectiveness and minimizing unnecessary side effects. Nanocarriers are essential in this process, allowing precise drug delivery to patient-specific targets, controlled release, improved bioavailability, and the creation of tailored combination therapies based on individual biological profiles. For instance, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, stated that in 2023, the United States Food and Drug Administration (FDA) approved 16 new personalized therapies for patients with rare diseases, a significant rise from merely six approvals in 2022. Consequently, the increasing demand for personalized medicines is a key driver for the nanocarriers market’s growth.

What Segment Categories Are Evaluated In The Nanocarriers Market Study?

The nanocarriers market covered in this report is segmented –

1) By Type: Polymeric Nanocarriers, Lipid-Based Nanocarriers, Inorganic Nanocarriers, Other Types

2) By Application: Drug Delivery, Diagnostics, Vaccines, Gene Therapy, Other Applications

3) By End-User: Pharmaceutical And Biotechnology Companies, Hospitals And Clinics, Research Institutes, Other End-Users

Subsegments:

1) By Polymeric Nanocarriers: Nanoparticles Of Poly Lactic Acid, Nanoparticles Of Poly Lactic-Co-Glycolic Acid, Nanoparticles Of Chitosan, Nanoparticles Of Gelatin, Nanoparticles Of Polycaprolactone

2) By Lipid-Based Nanocarriers: Solid Lipid Nanoparticles, Nanostructured Lipid Carriers, Liposomes, Nanoemulsions, Self-Emulsifying Drug Delivery Systems

3) By Inorganic Nanocarriers: Gold Nanoparticles, Silver Nanoparticles, Silica Nanoparticles, Magnetic Nanoparticles, Quantum Dots

4) By Other Types: Dendrimers, Protein-Based Nanocarriers, Carbon Nanotubes, Nanocrystals, Exosomes

What Trends Are Influencing The Nanocarriers Market?

Companies operating in the nanocarriers market are increasingly focusing on developing advanced formulations, particularly lipid nanoparticle technologies, to enhance targeted drug delivery and improve therapeutic effectiveness. Lipid nanoparticle technologies themselves are nanoscale, fat-based carriers designed for the safe and efficient delivery of drugs or genetic therapies to specific cells or tissues. As an illustration, in July 2023, Cytiva, a US-based biotechnology company, launched the NanoAssemblr commercial formulation system. This fully automated, single-use platform is engineered to support the entire clinical and commercial manufacturing process for lipid nanoparticle (LNP) medicines. The system leverages Cytiva’s NxGen technology to ensure controlled, reproducible mixing, thereby maintaining consistent quality from initial research stages through to large-scale manufacturing under cGMP conditions. This platform reduces the potential for cross-contamination through its single-use fluid path and facilitates efficient manufacturing of multiple products within a single facility. Additionally, it features intuitive software that complies with regulatory standards, automating workflows and enabling electronic batch records, which streamlines the production of genomic medicines such as mRNA vaccines, gene therapies, and cancer vaccines.

Which Organizations Are Involved In The Nanocarriers Market?

Major companies operating in the nanocarriers market are F. Hoffmann-La Roche Ltd, Pfizer Inc., Sanofi S.A., Novartis AG, Bristol-Myers Squibb Company, Amgen Inc., Evonik Industries AG, Matinas BioPharma Holdings Inc., Luye Pharma Group Ltd., Ascendia Pharmaceuticals Inc., Arcturus Therapeutics Holdings Inc., Nanobiotix S.A., Polymun Scientific Immunbiologische Forschung GmbH, ReCode Therapeutics Inc., Celsion Corporation, Starpharma Holdings Limited, EnGeneIC Ltd., Acuitas Therapeutics Inc., Altamira Therapeutics Ltd., Nanexa AB

Access The Complete Nanocarriers Market Report:

https://www.thebusinessresearchcompany.com/report/nanocarriers-global-market-report

Which Region Has The Strongest Presence In The Nanocarriers Market?

North America was the largest region in the nanocarriers market in 2025. The regions covered in the nanocarriers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Nanocarriers Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=28275&type=smp

Browse Through More Reports Similar to the Global Nanocarriers Market 2026, By The Business Research Company

Microcarrier Market Report 2026

https://www.thebusinessresearchcompany.com/report/microcarrier-global-market-report

Nanomaterials Market Report 2026

https://www.thebusinessresearchcompany.com/report/nanomaterials-global-market-report

Nanofibers Market Report 2026

https://www.thebusinessresearchcompany.com/report/nanofibers-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795